BioRender 图标

Enterocyte (epithelial���mesenchymal transition, stage 2)

Enterocyte (epithelial–mesenchymal transition, stage 2) - Editable icon of a cuboidal epithelial cell with a few microvilli undergoing epithelial-mesenchymal transition, stage 2 of 4

[{"image":"https://icons.cdn.biorender.com/w75xh75/5e28cb341def080027889b54/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e28cb341def080027889b54/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e28cb341def080027889b52/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e28cb341def080027889b52/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2485/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2485/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2486/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2486/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2487/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2487/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2488/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2488/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2489/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2489/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d248a/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d248a/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d248b/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d248b/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d248c/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d248c/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d248d/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d248d/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d248e/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d248e/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d248f/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d248f/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2490/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2490/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2491/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2491/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2492/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2492/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2493/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2493/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2494/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2494/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2495/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2495/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2496/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2496/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2497/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2497/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2498/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2498/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d2499/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d2499/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d249a/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d249a/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d249b/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d249b/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d249c/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d249c/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d249d/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d249d/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d249e/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d249e/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d249f/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d249f/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24a0/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24a0/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24a1/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24a1/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24a2/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24a2/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24a3/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24a3/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24a4/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24a4/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24a5/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24a5/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24a6/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24a6/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24a7/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24a7/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24a8/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24a8/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24a9/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24a9/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24aa/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24aa/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24ab/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24ab/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24ac/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24ac/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24ad/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24ad/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24ae/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24ae/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24af/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24af/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24b0/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24b0/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24b1/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24b1/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24b2/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24b2/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24b3/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24b3/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24b4/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24b4/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24b5/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24b5/5ca75b4b117774330009986e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f80c5a4ff7a190d24b6/5ca75b4b117774330009986e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f80c5a4ff7a190d24b6/5ca75b4b117774330009986e.png"}]

使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right

intestine,gi,gastrointestinal,intestinal,enterocyte,columnar cell,ciliated,epithelial cell,mesenchymal cell,stem cell,healing,wound,fibrosis,metastasis,cancer,epithelial,mesenchymal,EMT,transition,epithelial to mesenchymal transition,oncology

查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Enterocyte (epithelial���mesenchymal transition, stage 2) icon JPEG

Enterocyte (epithelial���mesenchymal transition, stage 2) icon PNG

Enterocyte (epithelial���mesenchymal transition, stage 2) icon SVG

Enterocyte (epithelial���mesenchymal transition, stage 2) icon GIF

BioRender 图标常见问题解答

How are scientists using the Enterocyte (epithelial���mesenchymal transition, stage 2) icon in their work?

BioRender users often use the Enterocyte (epithelial���mesenchymal transition, stage 2) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Enterocyte (epithelial���mesenchymal transition, stage 2) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Enterocyte (epithelial���mesenchymal transition, stage 2) icon customizable in BioRender?

Most icons in BioRender, including the Enterocyte (epithelial���mesenchymal transition, stage 2) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Enterocyte (epithelial���mesenchymal transition, stage 2) icon for publication or presentations?

Yes, figures containing the Enterocyte (epithelial���mesenchymal transition, stage 2) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Enterocyte (epithelial���mesenchymal transition, stage 2) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Enterocyte (epithelial���mesenchymal transition, stage 2) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Enterocyte (epithelial���mesenchymal transition, stage 2) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon